Brief: GT Biopharma Reports Fourth Quarter And Full-Year 2022 Financial Results And Provides Corporate Update
30/03/2023 22:40
March 30 (Reuters) - GT Biopharma Inc GTBP.O :
* GT BIOPHARMA REPORTS FOURTH QUARTER AND FULL-YEAR 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* GT BIOPHARMA -CASH ON HAND, COUPLED WITH SIGNIFICANT
RECENT COST
REDUCTION EFFORTS, EXPECTED TO PROVIDE AMPLE RUNWAY TO FUND
OPERATIONS INTO Q2 2024
* GT BIOPHARMA INC-NET LOSS OF $5.6 MILLION FOR Q4 OF 2022,
COMPARED TO A NET LOSS OF $18.0 MILLION FOR SAME QUARTER A YEAR
AGO
Source text for Eikon: ID:nGNX1nx5P4
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;;))